Form 8-K - Current report:
SEC Accession No. 0000950170-25-004613
Filing Date
2025-01-13
Accepted
2025-01-13 09:10:29
Documents
63
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eras-20250113.htm   iXBRL 8-K 44232
2 EX-99.1 eras-ex99_1.htm EX-99.1 64991
3 GRAPHIC eras-ex99_1s1.jpg GRAPHIC 898870
4 GRAPHIC eras-ex99_1s2.jpg GRAPHIC 1091267
5 GRAPHIC eras-ex99_1s3.jpg GRAPHIC 491417
6 GRAPHIC eras-ex99_1s4.jpg GRAPHIC 513158
7 GRAPHIC eras-ex99_1s5.jpg GRAPHIC 322217
8 GRAPHIC eras-ex99_1s6.jpg GRAPHIC 366128
9 GRAPHIC eras-ex99_1s7.jpg GRAPHIC 285122
10 GRAPHIC eras-ex99_1s8.jpg GRAPHIC 514091
11 GRAPHIC eras-ex99_1s9.jpg GRAPHIC 306903
12 GRAPHIC eras-ex99_1s10.jpg GRAPHIC 286607
13 GRAPHIC eras-ex99_1s11.jpg GRAPHIC 415398
14 GRAPHIC eras-ex99_1s12.jpg GRAPHIC 448770
15 GRAPHIC eras-ex99_1s13.jpg GRAPHIC 452202
16 GRAPHIC eras-ex99_1s14.jpg GRAPHIC 424478
17 GRAPHIC eras-ex99_1s15.jpg GRAPHIC 339268
18 GRAPHIC eras-ex99_1s16.jpg GRAPHIC 452235
19 GRAPHIC eras-ex99_1s17.jpg GRAPHIC 439123
20 GRAPHIC eras-ex99_1s18.jpg GRAPHIC 323975
21 GRAPHIC eras-ex99_1s19.jpg GRAPHIC 356891
22 GRAPHIC eras-ex99_1s20.jpg GRAPHIC 344269
23 GRAPHIC eras-ex99_1s21.jpg GRAPHIC 301261
24 GRAPHIC eras-ex99_1s22.jpg GRAPHIC 243959
25 GRAPHIC eras-ex99_1s23.jpg GRAPHIC 214962
26 GRAPHIC eras-ex99_1s24.jpg GRAPHIC 291951
27 GRAPHIC eras-ex99_1s25.jpg GRAPHIC 354224
28 GRAPHIC eras-ex99_1s26.jpg GRAPHIC 356770
29 GRAPHIC eras-ex99_1s27.jpg GRAPHIC 424454
30 GRAPHIC eras-ex99_1s28.jpg GRAPHIC 357101
31 GRAPHIC eras-ex99_1s29.jpg GRAPHIC 395284
32 GRAPHIC eras-ex99_1s30.jpg GRAPHIC 274405
33 GRAPHIC eras-ex99_1s31.jpg GRAPHIC 339017
34 GRAPHIC eras-ex99_1s32.jpg GRAPHIC 273391
35 GRAPHIC eras-ex99_1s33.jpg GRAPHIC 317412
36 GRAPHIC eras-ex99_1s34.jpg GRAPHIC 326899
37 GRAPHIC eras-ex99_1s35.jpg GRAPHIC 371770
38 GRAPHIC eras-ex99_1s36.jpg GRAPHIC 410924
39 GRAPHIC eras-ex99_1s37.jpg GRAPHIC 408576
40 GRAPHIC eras-ex99_1s38.jpg GRAPHIC 378106
41 GRAPHIC eras-ex99_1s39.jpg GRAPHIC 320481
42 GRAPHIC eras-ex99_1s40.jpg GRAPHIC 514190
43 GRAPHIC eras-ex99_1s41.jpg GRAPHIC 537522
44 GRAPHIC eras-ex99_1s42.jpg GRAPHIC 365939
45 GRAPHIC eras-ex99_1s43.jpg GRAPHIC 304355
46 GRAPHIC eras-ex99_1s44.jpg GRAPHIC 431888
47 GRAPHIC eras-ex99_1s45.jpg GRAPHIC 594590
48 GRAPHIC eras-ex99_1s46.jpg GRAPHIC 610000
49 GRAPHIC eras-ex99_1s47.jpg GRAPHIC 455676
50 GRAPHIC eras-ex99_1s48.jpg GRAPHIC 441320
51 GRAPHIC eras-ex99_1s49.jpg GRAPHIC 388100
52 GRAPHIC eras-ex99_1s50.jpg GRAPHIC 345229
53 GRAPHIC eras-ex99_1s51.jpg GRAPHIC 346638
  Complete submission text file 0000950170-25-004613.txt   28850266

Data Files

Seq Description Document Type Size
54 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eras-20250113.xsd EX-101.SCH 25793
65 EXTRACTED XBRL INSTANCE DOCUMENT eras-20250113_htm.xml XML 4879
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

EIN.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40602 | Film No.: 25525070
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)